First-line biological versus conventional synthetic disease-modifying antirheumatic drug therapy in adult-onset Still's disease: a multicentre, retrospective, propensity weighted cohort study

Kernder, Anna; Filla, Tim; Friedrich, Rhea; Blank, Norbert; Ernst, Diana; Henes, Joerg; Keysser, Gernot; Klemm, Philipp; Krusche, Martin; Meinecke, Anna; Rech, Juergen; Schulz, Nils; Petzinna, Simon Michael; Pankow, Anne; Schaefer, Valentin S.; Pfeil, Alexander; Klapa, Sebastian; Feist, Eugen; Vordenbaeumen, Stefan

First-line biological versus conventional synthetic disease-modifying antirheumatic drug therapy in adult-onset Still's disease: a multicentre, retrospective, propensity weighted cohort study

Autor(en):

Kernder, Anna; Filla, Tim; Friedrich, Rhea; Blank, Norbert; Ernst, Diana; Henes, Joerg; Keysser, Gernot; Klemm, Philipp; Krusche, Martin; Meinecke, Anna; Rech, Juergen; Schulz, Nils; Petzinna, Simon Michael; Pankow, Anne; Schaefer, Valentin S.; Pfeil, Alexander; Klapa, Sebastian; Feist, Eugen; Vordenbaeumen, Stefan

Tübinger Autor(en):

Henes, Jörg Christoph

Erschienen in:

Lancet Rheumatology (2025), Bd. 7, H. 6e415-e423

Verlagsangabe:

Amsterdam : Elsevier

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/S2665-9913(25)00023-2

ISSN:

2665-9913